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Abstract
Pellagra is a nutritional disease caused by the deficiency of niacin. We describe a case of pellagra as the initial presentation of Crohn
disease, which has been rarely described in the literature.
Introduction
In western countries, pellagra is rarely seen and is confined to individuals who have improper food intake such as psychiatric patients
or alcoholics and patients with malabsorptives states [1]. We report a case of pellagra as the initial presentation of Crohn disease in a
57-year-old female.
Case report
A 57-year-old woman presented for evaluation of a 3-week history of a skin rash involving her hands and feet. On physical examination
a symmetric bright scaly erythematous-brown eruption was observed on the dorsum of the hands and feet. On the feet the lesions
took on the configuration of her open shoes. Bullae at the calcaneal area as well as glossitis and marked edema of the lower legs
were also present.
Figure 1 Figure 2
Figure 1. Symmetric bright scaly erythematous-brown eruption on the hands.
Figure 2. Symmetric scaly eruption on the feet.
Figure 3 Figure 4
Figure 3. Bullous lesions at calcaneal area.
Figure 4. Marked edema of the lower leg.
2/9/2014 Pellagra as the initial presentation of Crohn disease [eScholarship]
http://escholarship.org/uc/item/0rd7m740 2/2
Figure 5
Figure 5. Slight atrophy of the
epidermis w ith orthokeratotic
hyperkeratosis and dermal
elastolysis w ith a discrete
inflammatory infiltrate (H&E, x40).
The skin lesions had a photosensitive distribution and were painful to touch. She complained about anorexia, fatigue, irritability, and
watery diarrhea in the last 2 months. She had no medical history of inflammatory bowel disease. However, she complained about
episodic abdominal pain, diarrhea, and a weight lost of 20 kg during the last 4 years. She was being treated with omeprazole for
several years and denied the intake of other drugs. Analytical studies revealed a normocytic normochromic anemia with hemoglobin of
9.2 g/dl (normal: >12), severe hypoproteinemia and hypoalbuminemia with total serum proteins of 3.0 g/dl (normal: >6.0) and albumin
of 0.8 g/dl (normal: >3.5), respectively. In addition, serum transferrin of 37 mg/dl (normal: >200), potassium of 3.1 mmol/l (normal:
>3.5) and calcium of 2.9 mmol/l (normal: <2.4) were documented. HIV serology was negative. A skin biopsy from the dorsum of the
hand was performed and showed slight atrophy of the epidermis with orthokeratotic hyperkeratosis and dermal elastolysis with a
discrete inflammatory infiltrate.
All the above findings were consistent with the diagnosis of pellagra. Endoscopic evaluation
showed the presence of bulbus stenosis and ileal ulcers; a biopsy showed noncaseating
granulomas, confirming the patient to have Crohn disease.
The patient was treated with albumin infusions and started on oral multivitamin supplementation
that contained 200 mg of niacin daily. Crohn disease was managed with oral prednisolone 1 mg/kg
daily and oral metronidazole 1 g daily. Skin lesions disappeared within 2 weeks after niacin
supplementation was initiated.
Discussion
Pellagra is a nutritional disease caused by the deficiency of niacin. It is a clinical syndrome characterized by 4 “D’s”: diarrhea,
dermatitis, dementia, and ultimately death [2]. Secondary pellagra can occur as a consequence of prolonged diarrhea, anorexia
nervosa, chronic alcoholism, chronic colitis, regional ileitis, carcinoid tumor, Hartnup disease, HIV disease, or medications such as 5-
fluorouracil, pyrazinamide or anticonvulsant drugs, among others [3, 4]. The dermatitis is a characteristic bilaterally symmetrical
eruption at cutaneous sites of solar exposure and tends to be painful to touch during the acute phase [5]. The back of the hands is the
most common area involved. The photosensitivity reaction may be the result of a deficiency of urocanic acid and/or cutaneous
accumulation of kynurenic acid [2]. When the cutaneous findings are present they are pathognomonic of the disease. However, if the
cutaneous features are absent it may go unrecognized. The diagnosis should focus on the presence of the 3 “D’s” and there are no
chemical tests available to definitively diagnose pellagra [2, 5]. Low levels of serum niacin, tryptophan, NAD and NADP, and low levels
of the urinary metabolites of N'-methyl-nicotinamide and N'-methyl-2-pyrindone-5-carboxamide are highly suggestive of the diagnosis
[2]. However, they aren’t currently available in most laboratories (as in our case). A rapid improvement of the skin lesions with niacin
supplementation also favors the diagnosis. Early neurologic symptoms may be misinterpreted and include insomnia, depression, or
fatigue [2, 6]. In pellagra, pathological changes in the skin are relatively nonspecific. Vesicles may be seen in the initial cutaneous
lesions as a result of vacuolar degeneration of the basal layer (also present in acrodermatitis enteropathica and necrolytic eythema).
This stage is followed by acanthosis with hyperkeratosis of the epidermis and in older lesions the process is characterized by atrophy
of the epidermis with flattening of the rete ridges and a chronic inflammatory infiltrate. A review of the literature confirms the paucity of
reports of the dermatosis as a complication of Crohn disease. It is even rarer as the initial manifestation of this inflammatory disease
[7, 8]. Because the disease is exceptional in developed countries, the degree of clinical suspicion is likely to be low; physicians must
be able to recognize this entity.
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